VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
about
Remodeling Components of the Tumor Microenvironment to Enhance Cancer TherapyDisrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects.RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells.miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosisCisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.The non-canonical role of vascular endothelial growth factor-C axis in cancer progressionMicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor PrognosisCharacterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer.Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling.Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901.RhoGDIβ Promotes Sp1/MMP-2 Expression and Bladder Cancer Invasion Through Perturbing miR-200c-Targeted JNK2 Protein Translation.Rho GDP dissociation inhibitor-β in renal cell carcinoma.Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer.VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
P2860
Q26777144-D5D6DD4A-98C8-4F60-AFC7-10CE7C3EE925Q28069761-52AB376C-0134-446A-9697-8F81E7EABDA9Q33977081-A43BA55F-DB86-434D-A4C3-56205DCC6D20Q35505165-ED02CE88-839C-4C0C-BDFF-AB12A0B2F85EQ35557027-10A13603-7A91-4365-B667-3CBA18BA3CB8Q36205905-C5354615-11B5-467B-8974-946C9405B6E2Q36548702-359020FE-C9E1-4993-BEE4-508C3BAC3DA1Q37071029-E979113B-AA5F-40CB-980F-F9AD8407EF6AQ37269340-EB2E23B9-58A7-407D-95E3-538446DAD39AQ37273742-A197A5EC-655F-4CF1-BE18-1FDC3223D7C0Q37295326-9EFC35FB-BCA4-46FA-B72E-C4F374576811Q37688272-02C4E0E5-0335-4AF6-A9A8-88D591DEC589Q38436106-55ECAC96-7932-410B-906C-031BAB9024F0Q38605628-140A260E-174E-45A5-9723-30CA1433AAE5Q47096248-B474E62C-AB2A-439C-8A19-30E653CB0295Q49886928-ACB8E6C4-22D4-4663-8DD7-4A1EA2EB9FD3Q52622142-FEE5A4EA-E275-41C0-BEC3-658DB93C07CEQ57291646-3D64F336-B5B3-4E87-A2BE-F4B6BE98442E
P2860
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
@en
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
@nl
type
label
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
@en
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
@nl
prefLabel
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
@en
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
@nl
P2093
P2860
P356
P1476
VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
@en
P2093
Chang Won Lee
Gyung-Hyuck Ko
Hee Jun Cho
In-Koo Nam
In-Kyu Kim
Jinhyun Ryu
Jungil Choi
Ki-Jun Ryu
P2860
P304
P356
10.1002/IJC.28801
P577
2014-03-04T00:00:00Z